74 related articles for article (PubMed ID: 19156082)
1. [Effectiveness of cerebrolysin in hypertensive supratentorial intracranial hemorrhages: results of a randomized triple blind placebo-controled study].
Maksimova MIu; Briukhov VV; Timerbaeva SL; Kistenev BA; Rebrova OIu; Suslina ZA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):20-6. PubMed ID: 19156082
[TBL] [Abstract][Full Text] [Related]
2. [Results of the multicenter prospective study of cerebrolysin safety and efficacy in acute stroke].
Skwortsova VI; Stakhovskaia LV; Shamalov NA; Kerbikov OB
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():41-5. PubMed ID: 18196634
[TBL] [Abstract][Full Text] [Related]
3. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
[TBL] [Abstract][Full Text] [Related]
4. [The effect of cerebrolysin in dosage 50 ml on the volume of lesion in ischemic stroke].
Shamalov NA; Stakhovskaia LV; Burenchev DV; Kichuk IV; Tvorogova TV; Botsina AIu; Smychkov AS; Kerbikov OB; Moessler H; Novak P; Skvortsova VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):34-7. PubMed ID: 21626816
[TBL] [Abstract][Full Text] [Related]
5. [Cerebrolysin treatment of mild cognitive impairment of vascular genesis].
Damulin IV; Mkhitarian EA; Koberskaia NN
Ter Arkh; 2007; 79(6):65-9. PubMed ID: 17684971
[TBL] [Abstract][Full Text] [Related]
6. Effects of cerebrolysin on functional recovery in patients with severe disability after traumatic brain injury: A historical cohort study.
Khalili H; Niakan A; Ghaffarpasand F
Clin Neurol Neurosurg; 2017 Jan; 152():34-38. PubMed ID: 27871029
[TBL] [Abstract][Full Text] [Related]
7. [Influence of cerebrolysin therapy on the dynamics of diabetic polyneuropathy symptoms].
Bogdanov EI; Sakovets TG; Gil'mullin IF
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):31-4. PubMed ID: 19770830
[TBL] [Abstract][Full Text] [Related]
8. [Use of cerebrolysin in the treatment of prolonged extrapyramidal complications of neuroleptic therapy].
Kontsevoĭ VA; Medvedev AV; Andrusenko MP; Zvenigorodskaia IuV; Sheshenin VS
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):39-44. PubMed ID: 11517474
[TBL] [Abstract][Full Text] [Related]
9. A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin treatment on clinical outcomes in traumatic brain injury.
Muresanu DF; Ciurea AV; Gorgan RM; Gheorghita E; Florian SI; Stan H; Blaga A; Ianovici N; Iencean SM; Turliuc D; Davidescu HB; Mihalache C; Brehar FM; Mihaescu AS; Mardare DC; Anghelescu A; Chiparus C; Lapadat M; Pruna V; Mohan D; Costea C; Costea D; Palade C; Bucur N; Figueroa J; Alvarez A
CNS Neurol Disord Drug Targets; 2015; 14(5):587-99. PubMed ID: 25924999
[TBL] [Abstract][Full Text] [Related]
10. [Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment].
Gavrilova SI; Kolykhalov IV; Fedorova IaB; Selezneva ND; Kalyn IaB; Roshchina IF; Odinak MM; Emelin AIu; Kashin AV; Gustov AV; Antipenko EA; Korshunova IuA; Davydova TA; Messler G
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):62-9. PubMed ID: 20436440
[TBL] [Abstract][Full Text] [Related]
11. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia--CASTA.
Hong Z; Moessler H; Bornstein N; Brainin M; Heiss WD;
Int J Stroke; 2009 Oct; 4(5):406-12. PubMed ID: 19765131
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous multiple hypertensive intracranial hemorrhages.
Takeuchi S; Takasato Y; Masaoka H; Hayakawa T; Yatsushige H; Sugawara T
J Clin Neurosci; 2011 Sep; 18(9):1215-8. PubMed ID: 21752649
[TBL] [Abstract][Full Text] [Related]
14. [The use of simvastatin in patients with hypertensive intracerebral hemorrhages].
Agmazov MK; Ivanova NE; Belinskaia VG; Toshpulatov ShP; Arzikulov TN
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):15-8. PubMed ID: 19672232
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
Ladurner G; Kalvach P; Moessler H;
J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.
Poon W; Matula C; Vos PE; Muresanu DF; von Steinbüchel N; von Wild K; Hömberg V; Wang E; Lee TMC; Strilciuc S; Vester JC
Neurol Sci; 2020 Feb; 41(2):281-293. PubMed ID: 31494820
[TBL] [Abstract][Full Text] [Related]
18. [Cerebrolysin in treatment of painful diabetic neuropathy].
Biesenbach G; Grafinger P; Eichbauer-Sturm G; Zazgornik J
Wien Med Wochenschr; 1997; 147(3):63-6. PubMed ID: 9173675
[TBL] [Abstract][Full Text] [Related]
19. [Mild forms of multi-infarct dementia: effectiveness of cerebrolysin].
Vereshchagin NV; Nekrasova EM; Lebedeva NV; Suslina ZA; Solov'ev OI; Piradov MA; Altunina MN
Sov Med; 1991; (11):6-8. PubMed ID: 1767322
[TBL] [Abstract][Full Text] [Related]
20. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease.
Alvarez XA; Cacabelos R; Laredo M; Couceiro V; Sampedro C; Varela M; Corzo L; Fernandez-Novoa L; Vargas M; Aleixandre M; Linares C; Granizo E; Muresanu D; Moessler H
Eur J Neurol; 2006 Jan; 13(1):43-54. PubMed ID: 16420392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
